APN News

  • Friday, October, 2019| Today's Market | Current Time: 05:39:58
  • Merck KGaA and sanofi-aventis Sign Agreement

    Germany : Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that Merck, has signed a worldwide research and development agreement with sanofi-aventis U.S. Inc., under which Merck Serono and sanofi-aventis U.S. Inc. will collaboratively investigate novel experimental combinations of agents that could block specific pathways in cancer cells. This collaboration could deliver […]

    DSM Nutritional Products Introduces Fabuless in Mumbai

    Mumbai : DSM Nutritional Products, the global Life company headquartered in Switzerland today officially introduced Fabuless in Mumbai, with Jörgen Quick, Marketing Manager, Weight Management, DSM Nutritional Products. The program included the introduction of the company and the ingredient, Fabuless with its unique role in weight management that helps “one to eat less”. With the […]

    Unichem Laboratories Ltd to Secure their Brands Against Counterfeiting

    Mumbai : Unichem and PharmaSecure today announced that Unichem has purchased 70 million of PharmaSecure’s codes to be applied for use in protecting its brand and consumers against counterfeiting and diversion. The unique identifier codes will be applied to several of Unichem’s leading medicines, including Trika for the treatment of anxiety and Losar for the […]

    Delhi Chief Minister Sheila Dikshit unveils Novalis Tx at Indraprastha Apollo Hospitals

    New Delhi:  Indraprastha Apollo Hospitals today launched Novalis Tx – a major advancement treating cancer. The technology was unveiled by the Delhi Chief Minister, Smt. Sheila Dikshit, in the presence of Dr Prathap C Reddy, Chairman, Apollo Hospitals Group. Novalis Tx is one of the most advanced, effective methods of radiotherapy and radio surgery. In […]

    Vascular Concepts to Set Up India’s First R&D and Manufacturing Facility for Endovascular Medical Devices

    Bangalore : The Rs 150 crore Bangalore based Vascular Concepts today outlined its plan to reinforce and build on its global leadership in cardiovascular technology. Vascular Concepts announced investments of over Rs fifteen crores to set up India’s first facility for R&D, design and manufacture of endovascular medical devices such as vascular stents, drug eluting […]

    Over Rs 90 crore grant for govt mental institutes, hosps

    The Union ministry of Health and Family welfare has released a grant of over Rs 90 crore for improving infrastructure in government mental hospitals and institutes. “The government has released a total of Rs 90.82 crore as financial assistance to strengthen 19 mental hospitals and institutes across the country,” a health ministry official said. He […]

    Over 450 reserved posts vacant in top govt hospitals

    The government said more than 450 posts under the reserved category were lying vacant in three top state-run hospitals in the national capital owing to various reasons. “498 reserved posts are lying vacant in three Central government hospitals — Safdarjung hospital, Dr Ram Manohar Lohia hospital and Lady Hardinge Medical College and associated hospitals on […]

    SafeMedTrip.com launches World Class Non Surgical Treatment for Fibroids

    New Delhi:  A simple scar-less procedure that requires just an overnight stay at the hospital has brought hope to women suffering from Fibroids, Adenomyosis and Endometriosis. Uterine Artery Embolization (UAE), a non-surgical treatment for fibroids is fast becoming popular the world over. Until now, the most common treatment for fibroid removal was hysterectomy. But the […]

    BGS Global Hospitals Equipped with Microdialysis facility for the brain – first in Asia

    Bangalore : Advanced Neurosciences Institute at BGS Global Hospitals, Bangalore, India, a part of the Global Hospitals Group is now equipped with Asia’s first microdialysis facility for the brain adding to its existing world class technology and infrastructure. Dr. N. K. Venkataramana, Chief Neurosurgeon and Vice-Chairman, BGS Global Hospitals said, “We are the first hospital […]

    New subgroup analysis of the LUX-Lung 1 trial suggests benefit from afatinib

    United States and Germany : New data to be presented show that afatinib  leads to a significant four-fold extension (4.4 months vs. 1 month for placebo) in progression-free survival, – the time before a tumour starts to grow again- , for lung cancer patients most likely to have an epidermal growth factor receptor (EGFR) mutation. […]